MBL2 and Huntington disease: Previously, our cross-sectional study also observed complement activation among 108 HD patients, representing a decreased level of plasma C3c and complement factor B (CFB), and an elevated level of plasma mannose-binding lectin (MBL), C3a and C5a, compared with normal controls [15].